F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, record review, and facility policy review the facility failed to obtain a physician order
for medication at the bedside, assess and document self-medication administration for Resident #45. This
affected one resident (#45) out of seven residents reviewed for medication administration. The facility
census was 97.
Residents Affected - Few
Findings Include:
Review of the medical record for Resident #45 revealed an admission date of 11/18/22. Diagnoses included
psoriasis, other pruritus, intrinsic allergic eczema, and chronic kidney disease stage 3.
Review of the physician order dated 11/14/23 indicated Triamcinolone Acetonide External Cream 0.5 %
(Triamcinolone Acetonide (Topical)), apply to arms, chest, trunk, legs topically every shift on Monday,
Tuesday, Wednesday and Thursday for eczema.
Review of the quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed no cognitive
impairment, and application of ointments/medications were applied other than to the feet during the
assessment period. There was no medication self-administration skills assessment.
Review of the Treatment Administration Records (TARs) from December 2023 through February 2024
indicated Triamcinolone was signed as administered by the nurses twice daily with no indication Resident
#45 was self-administering the medication.
Observation on 02/20/24 at 1:44 P.M. revealed one jar of Triamcinolone cream (used to treat eczema) on
Resident #45's bedside tray table. Interview at the time of the observation with Resident #45 indicated he
applied it for itchy skin when needed.
Observation on 02/21/24 at 11:03 A.M. revealed one jar of Triamcinolone cream on Resident #45's bedside
tray table. The prescription directions stated to apply to affected areas Monday through Thursday and to
take a break on the weekends. Interview at the time of the observation with Resident #45 reported the
prescription was from a non-facility pharmacy which he ordered independently and applied it when his skin
itched but followed the prescription instructions. Resident #45 stated the dermatologist educated him on
how and when to apply the medication but denied facility staff provided any instruction or oversight.
Interview on 02/21/24 at 11:05 A.M. with Registered Nurse (RN) #380 verified Resident #45 had a current
order for Triamcinolone cream and indicated it was kept at the bedside because Resident #45 applied it
himself. RN #380 explained the medication was kept at the bedside and Resident #45 was asked
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
366455
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366455
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/22/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mentor Ridge Health and Rehabilitation
8151 Norton Parkway
Mentor, OH 44060
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
whether the cream was applied, and if so, was documented as given. Sometimes Resident #45 would allow
the nurses to apply it. RN #380 indicated only seeing it applied a few times, but reported it was applied
correctly when observed. RN #380 confirmed there was no physician order for the medication to be kept at
bedside or for self-administration of the medication, and no documentation of the medication being
self-administered by Resident #45. RN #380 stated an order should have been obtained and denied
assessing Resident #45 for self-administration. RN #380 also stated being unaware of whether the
physician knew of the medication at the beside or being self-administered.
Interview on 02/21/24 at 11:11 A.M. with Assistant Director of Nursing (ADON) #386 denied knowledge of
the Triamcinolone medication at Resident #45's bedside for self-administration. ADON #386 indicated for
self-administration or medication at the bedside, a physician order was obtained, and a self-administration
skills assessment was completed. ADON #386 confirmed Resident #45 had no self-administration skills
assessment completed, and no physician order to keep the medication at the bedside for
self-administration.
Additional medical record review of Resident #45 revealed a new physician order was initiated on 02/21/24
at 11:43 A.M. for Triamcinolone Acetonide External Cream 0.5 % (Triamcinolone Acetonide (Topical)), apply
to arms, chest, trunk, legs topically every shift on Monday, Tuesday, Wednesday, and Thursday. May keep at
bedside and self-administer. A progress note dated 02/21/24 at 11:43 A.M. revealed the physician was
notified of Resident #45's wishes to self-administer topical Triamcinolone cream and store the medication in
the room at bedside. A self-medication administration assessment was completed which determined
Resident #45 was able to apply the medication, state its proper use and instructions. The physician agreed
to allow Resident #45 to self-administer and maintain the medication at bedside. A self-administration skills
assessment was initiated for Resident #45 on 02/21/24 at 11:35 A.M.
Review of the facility policy, Self-Administration of Medications, dated 10/30/17, revealed a resident may be
offered opportunity to self-administer medications once the physician and the interdisciplinary team concurs
the practice is safe and/or is part of discharge planning; self-administration of medications is documented
by the licensed nurse on the Medication Administration Record (MAR); and residents who self-administer
medications are re-assessed as needed and pursuant to a significant change in condition of the resident to
assure that safe self-administration of medications is still feasible.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366455
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
366455
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
02/22/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Mentor Ridge Health and Rehabilitation
8151 Norton Parkway
Mentor, OH 44060
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review, interview, and facility policy review the facility failed to monitor medication parameters per the
physician orders for Resident #40. This affected one resident (#40) of five residents reviewed for
unnecessary medications. The facility census was 97.
Residents Affected - Few
Findings include:
Review of the medical record for Resident #40 revealed an admission date of 08/30/23. Diagnoses included
Parkinson's disease, hypertension, morbid obesity, unspecified psychosis, and dementia.
Review of the quarterly Minimum Data Set (MDS) assessment dated [DATE] revealed Resident #40 had
severe cognitive impairment. Resident #40 was noted to require moderate assistance for upper body
dressing, personal hygiene, mobility, maximum assistance for bathing, and was dependent on staff for
toileting and lower body dressing.
Review of the physician orders for Resident #40 revealed an order dated 12/13/23 for Metoprolol Tartrate
oral tablet 25 milligrams (mg). Give 12.5 mg by mouth two times a day related to essential (primary)
hypertension. Hold for heart rate less than 60 or systolic blood pressure (SBP) less than 110.
Review of the Medication Administration Record (MAR) for February 2024 for Resident #40 revealed heart
rate and blood pressure monitoring were not completed twice daily per the physician's orders when
Metoprolol Tartrate was administered.
Interview on 02/22/24 at 12:00 P.M. with the Director of Nursing (DON) confirmed the parameters for
Metoprolol Tartrate were not being monitored per physician order for Resident #40.
Review of the facility policy titled Medication Administration, dated 06/21/2017, revealed under procedure
number one revealed to check medication administration record for order. Read label three times before
administering, comparing with the MAR.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
366455
If continuation sheet
Page 3 of 3